EMBODI Health Partners with ChiroTouch to Bring AI-Powered Remote Therapeutic Monitoring to 8,000+ Chiropractic Practices Nationwide

Strategic Integration Delivers SynapticAI™-Driven Patient Engagement Directly Inside the Industry's Most-Used Chiropractic EHR

Washington, DC — February 25, 2026 — EMBODI Health, the behavioral science and AI-powered Remote Therapeutic Monitoring (RTM) platform purpose-built for musculoskeletal care, today announced a landmark partnership with ChiroTouch, the leading practice management and EHR software serving more than 8,000 chiropractic practices across the United States. The integration gives ChiroTouch providers instant access to EMBODI's SynapticAI™ platform — embedding AI-driven patient adherence, gamified care programs, and automated RTM billing directly into their existing clinical workflow.

The partnership addresses one of the most persistent challenges in chiropractic care: keeping patients engaged and adherent between visits. Independent research has shown that poor patient adherence is responsible for up to 40% of avoidable treatment failures in musculoskeletal conditions. EMBODI's platform, validated across 4,188 patients in seven practices, has demonstrated a 40.48% improvement in patient retention and a 36.12% increase in practice revenue — results that will now be accessible to the entire ChiroTouch network.

"ChiroTouch serves more than 8,000 chiropractic practices across the United States. By embedding EMBODI inside their ecosystem, we're not just adding a feature, we're transforming how chiropractic practices deliver care, retain patients, and capture the revenue they deserve."

Dr. Jay Greenstein — Founder & CEO, EMBODI Health

What the Partnership Delivers

• Seamless EHR Integration: EMBODI's RTM platform connects natively within ChiroTouch, eliminating double-entry and enabling one-click program enrollment at the point of care.
• SynapticAI™ Behavioral Engine: Proprietary AI continuously analyzes patient engagement patterns and dynamically personalizes motivational touchpoints, exercise progressions, and re-engagement nudges — converting passive patients into active participants in their own recovery.
• Automated RTM Billing: CPT codes 98975, 98985, 98977, 98979, 98980 and 98981 are tracked and documented automatically, unlocking a new recurring revenue stream.
• Gamified Care Pathways: Evidence-based gamification mechanics drive the consistent home exercise and self-monitoring behaviors that improve clinical outcomes.
• Real-Time Provider Dashboard: Clinicians receive actionable engagement data between visits, enabling proactive outreach before patients disengage or drop out of care.

The Market Opportunity

The musculoskeletal RTM market is projected to exceed $2.8 billion by 2028, driven by CMS reimbursement expansion, rising demand for value-based care, and the documented ROI of patient engagement technology. Chiropractic represents one of the largest and most underserved segments of this market, with approximately 70,000 practicing chiropractors in the U.S. and fewer than 5% currently utilizing RTM billing codes — representing hundreds of millions of dollars in unrealized reimbursement annually.

The ChiroTouch partnership positions EMBODI at the center of this opportunity. With distribution access to 8,000 practices on day one, EMBODI is poised to move to enterprise-scale deployment, fundamentally altering its growth trajectory.

Clinical Validation

EMBODI's outcomes data is grounded in peer-reviewed research and real-world practice analytics. Published studies in the Journal of Medical Internet Research (JMIR, 2021 and 2023) established the behavioral science and gamification models underlying the platform. Proprietary data from multiple independent and 4,188 patients demonstrates:

• 40.48% improvement in patient retention rates
• 36.12% increase in practice revenue attributed to engagement-driven RTM billing
• Statistically significant improvements in patient-reported outcomes across musculoskeletal conditions

These results position EMBODI as one of the most clinically validated RTM platforms in the chiropractic market.